Doseloop Beta

Fleroxacin

medication Under review

A broad-spectrum fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV to treat various bacterial infections.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

Healthy-human research on fleroxacin is largely pharmacokinetic and safety-focused, with some volunteer studies showing tolerability at certain doses and measurable renal handling. Clinical trials in infected patients suggest antibacterial efficacy across several infection types, but those studies are not applicable to healthy-subject benefit claims. Among healthy volunteers, higher doses were associated with more adverse events, including photosensitivity, insomnia, nausea, and other intolerance symptoms. Overall, the evidence supports fleroxacin as an antibiotic with known dose-related side effects, not as a supplement with wellness benefits.

Reported Side Effects

Research (3 studies)

RCT

Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin

Antimicrobial Agents and Chemotherapy • 1989

Unknown

Preliminary

Renal tolerance of fleroxacin in healthy volunteers.

Journal of Antimicrobial Chemotherapy • 1988 • n=16

Mondorf AW, Buch A, Steinbacher G, RΓΌdel C, Falkenberg FW

RCT

Double-blind, dose-range-finding study of fleroxacin for treatment of complicated urinary tract infections

Antimicrobial Agents and Chemotherapy • 1987 • n=62

Unknown

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 3
Researched benefits 0
Side effects noted 4